ZA943494B - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- ZA943494B ZA943494B ZA943494A ZA943494A ZA943494B ZA 943494 B ZA943494 B ZA 943494B ZA 943494 A ZA943494 A ZA 943494A ZA 943494 A ZA943494 A ZA 943494A ZA 943494 B ZA943494 B ZA 943494B
- Authority
- ZA
- South Africa
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA943494B true ZA943494B (en) | 1995-01-23 |
Family
ID=10736007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA943494A ZA943494B (en) | 1993-05-21 | 1994-05-02 | Chemical compounds |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0699196A1 (xx) |
JP (1) | JPH08510455A (xx) |
CN (1) | CN1126473A (xx) |
AU (1) | AU6928794A (xx) |
BG (1) | BG100154A (xx) |
CA (1) | CA2162921A1 (xx) |
CZ (1) | CZ305195A3 (xx) |
FI (1) | FI955587A (xx) |
GB (1) | GB9310635D0 (xx) |
HU (1) | HUT73790A (xx) |
IL (1) | IL109703A0 (xx) |
NO (1) | NO954681D0 (xx) |
OA (1) | OA10195A (xx) |
PE (1) | PE31195A1 (xx) |
PL (1) | PL311702A1 (xx) |
SK (1) | SK142495A3 (xx) |
TW (1) | TW279866B (xx) |
WO (1) | WO1994027989A1 (xx) |
ZA (1) | ZA943494B (xx) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT75871A (en) * | 1993-09-30 | 1997-05-28 | Yamanouchi Co | Azole derivatives and pharmaceutical compositions thereof |
AU3846395A (en) * | 1994-11-07 | 1996-05-31 | Janssen Pharmaceutica N.V. | Compositions comprising carbazoles and cyclodextrins |
CN1177350A (zh) * | 1995-03-01 | 1998-03-25 | 山之内制药株式会社 | 咪唑衍生物及其药学组合物 |
CN1251577A (zh) * | 1997-02-21 | 2000-04-26 | 武田药品工业株式会社 | 稠环化合物及其生产和应用 |
CN100572363C (zh) | 2000-11-17 | 2009-12-23 | 武田药品工业株式会社 | 咪唑衍生物、其制备方法及其用途 |
ATE502030T1 (de) | 2000-11-20 | 2011-04-15 | Takeda Pharmaceutical | Imidazolderivate, verfahren zu deren herstellung und deren verwendung |
DE60139639D1 (de) | 2000-12-08 | 2009-10-01 | Takeda Pharmaceutical | Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung |
EP1902026B1 (en) | 2005-06-24 | 2010-02-17 | Eli Lilly And Company | Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
GB0525323D0 (en) * | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
CN100586932C (zh) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
UA105794C2 (uk) | 2009-06-26 | 2014-06-25 | Новартіс Аг | 1,3-ДИЗАМІЩЕНІ ПОХІДНІ ІМІДАЗОЛІДИН-2-ОНУ ЯК ІНГІБІТОРИ Cyp17 |
AU2011212813B2 (en) * | 2010-02-04 | 2014-10-23 | Radius Health, Inc. | Selective androgen receptor modulators |
ME02474B (me) | 2010-05-12 | 2017-02-20 | Radius Health Inc | Terapijski režimi |
US9132105B2 (en) | 2010-08-04 | 2015-09-15 | Pellficure Pharmaceuticals, Inc. | Treatment of prostate carcinoma |
US8946260B2 (en) | 2010-09-16 | 2015-02-03 | Novartis Ag | 17α-hydroxylase/C17,20-lyase inhibitors |
EP2621901B1 (en) | 2010-09-28 | 2015-07-29 | Radius Health, Inc | Selective androgen receptor modulators |
ES2656218T3 (es) | 2011-04-28 | 2018-02-26 | Novartis Ag | Inhibidores de 17 alfa-hidroxilasa/C17,20-liasa |
US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
CA2902335C (en) | 2013-03-14 | 2021-09-14 | Pellficure Pharmaceuticals, Inc. | Novel therapy for prostate carcinoma |
US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
DK3122426T3 (da) | 2014-03-28 | 2023-04-03 | Univ Duke | Behandling af brystcancer ved anvendelse af selektive østrogenreceptormodulatorer |
US10093620B2 (en) | 2014-09-12 | 2018-10-09 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
LT3474841T (lt) | 2016-06-22 | 2022-06-10 | Ellipses Pharma Ltd | Ar+ krūties vėžio gydymo būdai |
EP3528799A1 (en) | 2016-10-24 | 2019-08-28 | Pellficure Pharmaceuticals, Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
PL3565542T3 (pl) | 2017-01-05 | 2024-07-29 | Radius Pharmaceuticals, Inc. | Postacie polimorficzne rad1901-2hcl |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/xx unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 EP EP94917647A patent/EP0699196A1/en not_active Withdrawn
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/cs unknown
- 1994-05-19 CN CN94192683A patent/CN1126473A/zh active Pending
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/en not_active Application Discontinuation
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-19 JP JP7500181A patent/JPH08510455A/ja active Pending
- 1994-05-19 SK SK1424-95A patent/SK142495A3/sk unknown
- 1994-05-19 PL PL94311702A patent/PL311702A1/xx unknown
- 1994-05-19 HU HU9503321A patent/HUT73790A/hu unknown
- 1994-05-19 CA CA002162921A patent/CA2162921A1/en not_active Abandoned
- 1994-05-20 IL IL10970394A patent/IL109703A0/xx unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/es not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 NO NO954681A patent/NO954681D0/no unknown
- 1995-11-20 FI FI955587A patent/FI955587A/fi not_active Application Discontinuation
- 1995-11-21 BG BG100154A patent/BG100154A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BG100154A (en) | 1996-07-31 |
TW279866B (xx) | 1996-07-01 |
OA10195A (en) | 1996-12-18 |
PE31195A1 (es) | 1995-10-18 |
AU6928794A (en) | 1994-12-20 |
PL311702A1 (en) | 1996-03-04 |
CN1126473A (zh) | 1996-07-10 |
FI955587A0 (fi) | 1995-11-20 |
NO954681L (no) | 1995-11-20 |
GB9310635D0 (en) | 1993-07-07 |
JPH08510455A (ja) | 1996-11-05 |
EP0699196A1 (en) | 1996-03-06 |
IL109703A0 (en) | 1994-08-26 |
FI955587A (fi) | 1995-11-20 |
WO1994027989A1 (en) | 1994-12-08 |
HUT73790A (en) | 1996-09-30 |
SK142495A3 (en) | 1996-06-05 |
NO954681D0 (no) | 1995-11-20 |
CZ305195A3 (en) | 1996-06-12 |
CA2162921A1 (en) | 1994-12-08 |
HU9503321D0 (en) | 1996-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9304618D0 (en) | Chemical compounds | |
GB9301000D0 (en) | Chemical compounds | |
GB9311682D0 (en) | Chemical compounds | |
GB9312210D0 (en) | Chemical compounds | |
GB9305468D0 (en) | Chemical compounds | |
PL311702A1 (en) | Chemical compounds | |
GB9305469D0 (en) | Chemical compounds | |
GB2280677B (en) | Chemical compounds | |
GB9308421D0 (en) | Chemical compounds | |
GB9307749D0 (en) | Chemical compounds | |
GB9305509D0 (en) | Chemical compounds | |
GB9305523D0 (en) | Chemical compounds | |
GB9305510D0 (en) | Chemical compounds | |
GB9305459D0 (en) | Chemical compounds | |
GB9305806D0 (en) | Chemical compounds | |
GB9300882D0 (en) | Chemical compounds | |
GB9310560D0 (en) | Chemical compounds | |
GB9307806D0 (en) | Chemical compounds | |
GB9307809D0 (en) | Chemical compounds | |
GB9304641D0 (en) | Chemical compounds | |
GB9304640D0 (en) | Chemical compounds | |
GB9300558D0 (en) | Chemical compounds | |
GB9300557D0 (en) | Chemical compounds | |
GB9301092D0 (en) | Chemical compounds | |
GB9307398D0 (en) | Chemical compounds |